Guidelines versus individualized care for the management of CINV-Reference-Cited by-同舟云学术

Guidelines versus individualized care for the management of CINV

Published:2018-03 Issue:S1 Volume:26 Page:11-17
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Clemons Mark^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-018-4115-3.pdf

Reference31 articles.

1. Roila F, Molassiotis A, Herrstedt J, participants of the MASCC/ESMO Consensus Conference Copenhagen 2015 et al (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 27(suppl 5):v119–v133 http://www.mascc.org/assets/Guidelines-Tools/mascc_antiemetic_guidelines_english_2016_v.1.2.pdf . Accessed 1 July 2017

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Antiemesis. Version 2.2017. Available at: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf . Accessed 1 July 2017.

3. Hesketh PJ, Kris MG, Basch E et al (2017) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:3240–3261

4. Grunberg SM, Osoba D, Hesketh PJ et al (2005) Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update. Support Cancer Cancer 13:80–84

5. Hannigan EV, Green S, Alberts DS, O’Toole R, Surwit E (1993) Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer. Oncology 50(Suppl 2):2–9

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symptom clusters and their impact on quality of life among Chinese patients with lung cancer: A cross-sectional study;European Journal of Oncology Nursing;2023-12

2. Real-world validation of the chemotherapy-induced nausea and vomiting predictive model and its optimization for identifying high-risk Chinese patients;Chinese Medical Journal;2023-04-27

3. Non-pharmacological management for chemotherapy-induced nausea and vomiting in patients with cancer: a scoping review^†;Frontiers of Nursing;2023-03-01

4. Response to comment on “Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy”;Journal of Oncology Pharmacy Practice;2023-01-30

5. Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug;Current Oncology;2022-10-31